Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

COVID-19 In Vitro Diagnostic Devices and Test Methods Database

The objective of the JRC COVID-19 In Vitro Diagnostic Devices and Test Methods Database is to collect in a single place all publicly available information on performance of CE-marked in vitro diagnostic medical devices (IVDs) as well as laboratory-developed devices and related test methods for COVID-19. The database is manually curated and periodically updated.

Aim of the website 

Browse the data

COVID-19 in vitro diagnostic medical devices

The database contains publicly available in vitro diagnostic medical devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark.
Quick searches
This section of the database is based on publicly available information from manufacturers.
The conformity of the devices with applicable EU law has NOT been in any way assessed by the European Commission or Member State national authorities for the purposes of inclusion in the database. There is no central approval system for in vitro diagnostic medical devices in the EU and the database does NOT represent a list of authorised or approved devices in the European Union.
For rapid antigen tests, as part of the EU Health Security Committee (HSC), the Member States have agreed on a common list of these tests considered appropriate for use in the context of COVID-19 diagnosis, as well as a selection of these whose results should be mutually recognised.
For more information, please read “ Aim of the website”.

SARS-CoV-2 NAAT target regions

The database provides pre-computed values corresponding to the extent of matchings of the primers and probes from NAAT database methods against high-quality, full length genomic sequences, which are made available by GISAID to enable this analysis.

EUnetHTA publications repository

EUnetHTA - European Network for Health Technology Assessment – developed a COVID-19-related repository of publications and outputs produced jointly or by individual HTA organisations on testing methods and devices for SARS-COV-2.

Explore the data

This section allows surfing in and mining of data and analyses performed on SARS-CoV-2 sequences, like detectability of NAAT amplicons, and the phylodynamics of the pandemic in the European Union countries.


Additional information for manufacturers 

Submit / Update your device

Manufacturers are invited to submit information on new devices not yet listed or to provide performance data not available to the authors at the time of the last update. The submitted information, once verified against the source provider, will be taken into consideration for updating the database.

Info for the EU common list on antigen tests


IMPORTANT NEWS on HSC Technical Working Group activity

Please note that the work of the technical working group on COVID-19 diagnostic tests has formally ended.
Manufacturers were able to submit applications for antigen devices to be included in the EU common list until 31 March 2023, 23:59 CET.
Since then, no new applications have been considered or assessed.
The technical working group and its activities formally stopped on 30 June 2023, with the end of validity of the EU Digital COVID Certificate Regulation.

Related links